Is SSRX a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

209 people get SSRX articles and Market Currents by email alert.

Get email alerts on SSRX »

HEADLINES:

China Biotech In Review: Chindex Buys Israeli Laser Company For $240 Million
ChinaBio Today • Sun, May 5
3SBio Inc. Announces Extraordinary General Meeting of Shareholders

PR Newswire (May 2, 2013)
3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

PR Newswire (May 1, 2013)
China Biotech In Review: WuXi PharmaTech Contributes To Syros Pharma Funding
ChinaBio Today • Sun, Apr 28
3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

PR Newswire (Apr 25, 2013)
3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction

PR Newswire (Apr 24, 2013)
3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders

PR Newswire (Apr 22, 2013)
3SBio Inc. Announces Extraordinary General Meeting of Shareholders

PR Newswire (Mar 24, 2013)
3SBio's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Mar 19
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results

PR Newswire (Mar 18, 2013)
3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results

PR Newswire (Mar 3, 2013)
China Biotech In Review: Cardinal Health Uses M&A To Add Drug Distribution Reach
ChinaBio Today • Sun, Feb 10
3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction

PR Newswire (Feb 8, 2013)
Money Managers Are Selling These 6 Illiquid Stocks
Kapitall • Mon, Jan 21 • 1 Comment
3SBio: Mexican Stand-Off
Growth Stock Insider • Mon, Jan 14 • 2 Comments
9 Chinese Stocks Being Sold Off By Hedge Funds
Kapitall • Thu, Jan 10 • 2 Comments
4 High-Growth Stocks In Deep Discount With Big Upside Potential
Arie Goren • Fri, Dec 7, 2012 • 3 Comments
3SBio's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Mon, Nov 12, 2012
3SBio Inc. Announces Unaudited Third Quarter 2012 Results

PR Newswire (Nov 11, 2012)
6 China Stocks Going Private Since September 2012
Markus Aarnio • Mon, Oct 15, 2012 • 22 Comments

To learn more about Seeking Alpha Pro, click here.

3SBio: Mexican Stand-Off
Growth Stock Insider • Mon, Jan 14 • 2 Comments
3-S Bio: Unit Volume Rises, Costs Decline
Growth Stock Insider • Fri, May 18, 2012
3-S Bio Brushes Off Regulatory Threat
Growth Stock Insider • Thu, Mar 15, 2012
3SBio Buys China Rights to Kidney Transplant Drug
ChinaBio Today • Thu, Aug 26, 2010
3SBio, Ascentage Form Alliance to Develop Cancer Drugs
ChinaBio Today • Sun, Feb 14, 2010 • 1 Comment
3SBio Gains China Rights to Another Dialysis Drug
ChinaBio Today • Tue, Feb 9, 2010
3SBio Reports Higher Sales, Flat Earnings
ChinaBio Today • Fri, Mar 13, 2009
3SBIO Files for Approval on Three New Drugs
ChinaBio Today • Wed, Jan 21, 2009 • 1 Comment
3SBio's Q3 Hurt by Lehman Bankruptcy
ChinaBio Today • Tue, Nov 4, 2008
3SBio Files for Approval of Anemia Treatment
ChinaBio Today • Fri, Sep 26, 2008
3SBio Reports Higher Q2 Revenues but Earnings Slip
ChinaBio Today • Thu, Aug 14, 2008
Is 3SBio Too Conservative to Move Forward?
ChinaBio Today • Wed, Jul 2, 2008 • 1 Comment
3SBio to Commercialize Iron Deficiency Agent in China
ChinaBio Today • Wed, May 28, 2008
3SBio’s Q1: Revenues Rise, Net Income Lags
ChinaBio Today • Fri, May 16, 2008
3SBio Finally Pleases Investors
ChinaBio Today • Mon, Mar 24, 2008
Is 3SBio the Chinese Amgen?
George Spritzer • Tue, Feb 26, 2008 • 1 Comment
3SBio Drops on Missed Estimates
ChinaBio Today • Fri, Feb 22, 2008
3SBio Plunges on Q4 Earnings Miss
Timothy Roe • Fri, Feb 22, 2008
3SBio Bucks The Trend: Reports Impressive Earnings, Stock Jumps
ChinaBio Today • Thu, Nov 15, 2007
3SBio Rises After Hours on Earnings
Timothy Roe • Wed, Nov 14, 2007

China Biotech In Review: Chindex Buys Israeli Laser Company For $240 Million
ChinaBio Today • Sun, May 5
China Biotech In Review: WuXi PharmaTech Contributes To Syros Pharma Funding
ChinaBio Today • Sun, Apr 28
China Biotech In Review: Cardinal Health Uses M&A To Add Drug Distribution Reach
ChinaBio Today • Sun, Feb 10
Money Managers Are Selling These 6 Illiquid Stocks
Kapitall • Mon, Jan 21 • 1 Comment
9 Chinese Stocks Being Sold Off By Hedge Funds
Kapitall • Thu, Jan 10 • 2 Comments
4 High-Growth Stocks In Deep Discount With Big Upside Potential
Arie Goren • Fri, Dec 7, 2012 • 3 Comments
6 China Stocks Going Private Since September 2012
Markus Aarnio • Mon, Oct 15, 2012 • 22 Comments
QE3 Can Likely Produce 10% Short-Term Gain
David Brown • Mon, Sep 17, 2012 • 5 Comments
China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture
ChinaBio Today • Sun, Sep 16, 2012 • 1 Comment
4 Cash Loaded Biotech Stocks With Little Debt
ZetaKap • Thu, Aug 30, 2012 • 4 Comments
Micro Cap Biotech Stocks Being Accumulated By The World's Largest Money Managers
GuruFundPicks • Wed, Jul 11, 2012 • 9 Comments
3 Cash-Hoarding Biotech Stocks With Solid Profits
ZetaKap • Wed, Jul 4, 2012
4 High-Growth Chinese Stocks With Strong Receivable Trends
Kapitall • Thu, Jun 21, 2012
4 Highly Liquid Biotech Stocks With Strong Receivable Trends
Kapitall • Wed, May 23, 2012
4 High-Growth Chinese Stocks With Strong Sales Trends
Kapitall • Wed, May 16, 2012 • 2 Comments
3 Undervalued Chinese Small Caps With Strong Receivable Trends
Kapitall • Thu, Apr 26, 2012 • 1 Comment
8 Highly Liquid Healthcare Stocks Undervalued By EPS Trends
Kapitall • Wed, Apr 18, 2012
5 Undervalued Healthcare Stocks With Positive Receivables Trends
Kapitall • Thu, Apr 12, 2012
3 Highly Liquid Biotech Stocks With Positive Receivable Trends
Kapitall • Tue, Apr 10, 2012 • 1 Comment
Chinese Stocks That Are Best To Own Through May
The Oxen Group • Tue, Apr 10, 2012 • 1 Comment

3SBio's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Mar 19
3SBio's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Mon, Nov 12, 2012
3SBio Inc. Q4 2009 Earnings Call Transcript
Fri, Feb 12, 2010
3SBio Inc. Q3 2009 Earnings Call Transcript
Fri, Nov 13, 2009
3SBio Inc. Q3 2008 Earnings Call Transcript
Tue, Nov 11, 2008
3SBio Inc. Q2 2008 Earnings Call Transcript
Wed, Aug 13, 2008

3SBio Inc. Announces Extraordinary General Meeting of Shareholders

PR Newswire (May 2, 2013)
3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

PR Newswire (May 1, 2013)
3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

PR Newswire (Apr 25, 2013)
3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction

PR Newswire (Apr 24, 2013)
3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders

PR Newswire (Apr 22, 2013)
3SBio Inc. Announces Extraordinary General Meeting of Shareholders

PR Newswire (Mar 24, 2013)
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results

PR Newswire (Mar 18, 2013)
3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results

PR Newswire (Mar 3, 2013)
3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction

PR Newswire (Feb 8, 2013)
3SBio Inc. Announces Unaudited Third Quarter 2012 Results

PR Newswire (Nov 11, 2012)
3SBio Inc. Announces Results Of 2012 Annual General Meeting

PR Newswire (Oct 13, 2012)
3SBio Inc. Schedules Unaudited Third Quarter 2012 Results

PR Newswire (Oct 8, 2012)
3SBio Independent Committee Selects Financial Advisor in Connection with Going Private Proposal

PR Newswire (Sep 28, 2012)
3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal

PR Newswire (Sep 16, 2012)
3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS

PR Newswire (Sep 12, 2012)
3SBio Inc. to Hold 2012 Annual General Meeting on October 10, 2012

PR Newswire (Sep 10, 2012)
Health Care Sector Wrap

at Fox Business (Aug 16, 2012)
Health Care Sector Wrap

at Fox Business (Aug 16, 2012)
Health Care Sector Wrap

at Fox Business (Aug 16, 2012)
Health Care Sector Wrap

at Fox Business (Aug 16, 2012)

SSRX vs. ETF Alternatives

Company Description

Currently, there's no company description for SSRX.

Sector: Healthcare

Industry: Biotechnology

Country: China

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, April 24, 12:34 PM 3SBio (SSRX +1%) says its entered into an Amendment to Merger Agreement with its Chairman and CEO Dr. Jing Lou, along with private equity partner CITIC, for the sweetened offer of $16.70 per ADS from its previous offer of $15. The increase represents an approximately 8.4% premium to the original merger consideration. Comment! [Global & FX, Healthcare, M&A, On the Move]
Monday, April 22, 2:27 PM More on 3SBio (SSRX): The company says it's received an amended "go private" from its Chairman and CEO Dr. Jing Lou and private equity partner CITIC, increasing their offer to $16.70 per ADS from its previous offer of $15, which had been rejected by SSRX. In light of the new offer, the company says it will still hold the extraordinary shareholder meeting on Thursday, but will adjourn without voting in order to consider the new proposal. Shares remain halted. Comment! [Healthcare, Global & FX, M&A, On the Move]
Monday, April 22, 2:14 PM Shares of 3SBio (SSRX +1.3%) have been halted with news pending. The company is holding an extraordinary general meeting of shareholders on Thursday to consider and vote on the proposed plan to be taken private by Decade Sunshine in a deal valuing the China-based biotech at around $350M. Comment! [Healthcare, On the Move, Global & FX, M&A]
Tuesday, March 19, 6:15 AM 3SBio (SSRX): Q4 EPS of $0.12 misses by $0.02. Revenue of $26.3M beats by $0.7M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Friday, February 8, 12:55 PM Aegis Capital cuts 3SBio (SSRX +6%) from Buy to Hold on the back of today's announcement of being taken private, saying that the current merger terms substantially undervalue the company. Comment! [M&A, On the Move]
Friday, February 8, 9:53 AM 3SBio (SSRX +7.2%) agrees to be taken private by Decade Sunshine in a deal valuing the China-based biotech at ~$350M. SSRX shareholders will get $2.20/share in cash, or $15.40 per ADS. Comment! [Healthcare, M&A, On the Move]
Wednesday, September 12, 2012, 9:11 AM 3SBio (SSRX) says it received a going-private proposal from its Chairman and CEO for $15/share, a 29% premium to yesterday's closing price. The acquisition would be financed through a combination of debt and equity capital, with a financial institution having expressed interest in financing the deal. Shares +20.7% premarket. 1 Comment [Healthcare, M&A, On the Move]
Wednesday, September 12, 2012, 9:10 AM Premarket gainers: MEDW +39%. SSRX +21%. JVA +18%. NBG +13%. FB +7%. YOKU +6%. NOK +6%. AUO +5%.
Losers: GCOM -19%. ONCY -18%. PURE -16%. XRTX -15%. MTG -11%. CIG -11%. HK -7%. Comment! [On the Move]
Wednesday, August 15, 2012, 5:53 AM 3SBio (SSRX): Q2 EPS of $0.29 beats by $0.02. Revenue of $28.1M (+31% Y/Y) beats by $0.3M. (PR) Comment! [Earnings, Healthcare]

Asif Suria
3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS $SSRX http://bit.ly/NZl4E5
9/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Cash Loaded Biotech Stocks With Little Debt http://bit.ly/NYQlHb $CYCC $OMPI $SSRX $VNDA @ZetaKap
8/30/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

The Wall Street Transcript
Medical Research Service and Biotech Continues to Grow in China; 3SBio Inc. ($SSRX) a Top Pick- http://su.pr/2SO7kz
8/27/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
3 Cash-Hoarding Biotech Stocks With Solid Profits http://bit.ly/LZCLlS $OMPI $SSRX $VPHM @ZetaKap
7/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Tony Kau
Today's Top Trend Exhaustion Buys: $SSRX $IPI $ ITC $JNPR $ILMN $EQT $NIHD $AVP $STI $WAT http://tinyurl.com/7cwak4b
12/13/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Kapitall
[new post] 10 Small Cap Management Teams To Watch In 2011 http://bit.ly/gfnI9X $ADC $CKSW $GSOL $LABL $LINC $NRCI $PLPC $SSRX
1/6/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

stockchartreader
Along with market-wide rally today, China-based $SSRX climbs 3% - up nearly 18% in past two weeks.
11/4/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

John Ward
"Medical-biomed/biotech" MNTA BMRN VPHM SSRX
7/31/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

The GeoTeam
These companies reported strong qtrs: 3 Sbio (SSRX) China Transinfo (CTFO) E-House China (EJ) China Automotive (CAAS) Wuxi Pharmatech (WX)
8/12/09
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

SSRX 3SBio Inc.

SSRX

3SBio Inc.